Type 2 diabetes mellitus (T2DM) represents a major health burden for the elderly
population, affecting approximately 25% of people over the age of 65 years. This percentage …

Background Sarcopenia and cognitive impairment are two of the most prevalent causes of
disability in the aging population. Despite the vast amount of research that has been done to …

Objectives Sarcopenia, defined as an age-associated loss of skeletal muscle function and
muscle mass, occurs in approximately 6-22% of older adults. This paper presents evidence …

Sarcopenia is a progressive skeletal muscle disorder involving the loss of muscle mass and
function, associated with an increased risk of disability and frailty. Though its prevalence in …

Background & aims Sarcopenia is a muscle disorder associated with loss of muscle mass,
strength and function. Early screening, diagnosis and treatment may improve outcome in …

The age-related decrease in skeletal muscle mass together with the loss of muscle power
and function is defined sarcopenia. Mounting evidence suggests that the prevalence of …

Aims Sarcopenia has recently been shown to affect quality of life and mortality in patients
with diabetes. However, early detection requires an expensive equipment. We hypothesized …

The elderly people are characterized by multiple comorbidities, dementia, and are at risk of
developing sarcopenia and frailty. Sarcopenia is defined by loss of muscle mass and muscle …

Background: Sarcopenia and frailty are found in up to one-third of the general elderly
population. Both are associated with major adverse health outcomes such as nursing home …

Background A link between sarcopenia and cognitive function has been proposed and is
supported by several investigations. Nevertheless, the sex-linked relationship between …